-
- Posted Tuesday September 15, 2015
Atlanta Golf Classic closes in on $1 million in charitable giving
6th annual tournament has raised $800,000 in first 5 years for TGen pancreatic cancer research
ATLANTA - Sept. 15, 2015 - Golfers and
non-golfers alike will swing toward $1 million in charitable giving
in the upcoming Howard Young's 6th annual Atlanta Golf Classic,
slated for Sept. 29 at the spectacular Capital City Club at
Crabapple in Alpharetta.
In the past 5 years, the event has raised more than $800,000 in
support of pancreatic cancer research at the Phoenix-based Translational
Genomics Research Institute (TGen).
All funds go to TGen's research into early detection and better
treatments for pancreatic cancer, the nation's fourth leading cause
of cancer-related death.
"I have now survived 13 years with this most aggressive of cancers
thanks to the incredible work done at TGen and its
Physician-In-Chief Dr. Daniel Von Hoff," said Howard Young, an
Atlanta businessman who credits TGen and Dr. Von Hoff with saving
his life.
Dr. Von Hoff, who is world renowned for his contributions to
pancreatic cancer research, has led teams that were instrumental in
the development of major anti-pancreatic cancer agents that have
significantly improved patients' survival.
"With a little help from our friends, we could come close to
reaching the $1 million mark this year," said Young, a Board Member
of the TGen Foundation, and chair of its National Pancreatic Cancer
Committee.
The tournament field, limited to 120 golfers, is expected to sell
out, as it has in past years.
Pancreatic cancer this year will take the lives of more than
40,000 Americans, making it the nation's fourth leading cause of
cancer-related death. Median survival for patients with advanced
disease is less than 6 months following diagnosis, and the 5-year
survival rate is less than 10 percent for all patients.
Pancreatic cancer's lethal nature stems from its propensity to
rapidly spread to distant organs, especially the liver and the
lungs. Survival remains low partly because no early screening test
exists.
The Atlanta Golf Classic is held in association with the
Scottsdale-based Seena Magowitz Foundation.
"The remarkable fundraising efforts of Howard Young, a long-time
pancreatic cancer survivor, gives testament to value of the
advances being made by TGen and Dr. Von Hoff," said Roger E.
Magowitz, Presidentof the Seena Magowitz Foundation, which he
founded in honor of his mother, Seena, whodied of pancreatic
cancer in 2001.
This 6th annual tournament will be co-hosted by Howard Young, John
Morley, Randy Dobbs, and Jane and Bill Young.
Registrations and donations are still being accepted, and
non-golfers are invited to attend the tournament's awards luncheon.
Please contact Tournament Director Liz McBeth at [email protected]
or (757) 773-3622.
For more information, visit www.seenamagowitzfoundation.org/atlanta-golf-classic,
or contact Roger E. Magowitz at [email protected]
or 602-524-7636.
To learn more about TGen's work in pancreatic cancer, watch a
video that includes Howard Young, his wife Becky Young, Roger E.
Magowitz, Dr. Daniel Von Hoff, TGen President Dr. Jeffrey Trent,
TGen Foundation President Michael Bassoff, former U.S. Vice
President and TGen Foundation Board Member Dan Quayle, Arizona
Diamondbacks President & CEO Derrick Hall, New York Yankees
Senior Vice President & General Manager Brian Cashman, Leggett
& Platt Inc. President and CEO Karl Glassman, and Mattress Firm
Executive Vice President Karrie Forbes, at: www.seenamagowitzfoundation.org.
# # #
About the Seena Magowitz Foundation
The Seena Magowitz Foundation is a 501(c)(3) non-profit
organization committed to advancing the awareness and eventual
prevention and cure of pancreatic cancer. The Foundation is
dedicated to funding top medical institutions on the leading edge
of translational pancreatic cancer research committed to diagnosis,
the advancement of life-extending treatment options and the
ultimate goal of eradicating this deadly killer. For more
information, visit: www.seenamagowitzfoundation.org.
*
About TGen
Translational Genomics Research Institute (TGen) is a Phoenix,
Arizona-based non-profit organization dedicated to conducting
groundbreaking research with life changing results. TGen is focused
on helping patients with neurological disorders, cancer, and
diabetes, through cutting edge translational research (the process
of rapidly moving research towards patient benefit). TGen
physicians and scientists work to unravel the genetic components of
both common and rare complex diseases in adults and children.
Working with collaborators in the scientific and medical
communities literally worldwide, TGen makes a substantial
contribution to help our patients through efficiency and
effectiveness of the translational process. For more information,
visit:www.tgen.org. Follow TGen on Facebook, LinkedIn and Twitter @TGen.
Press Contact:
Steve Yozwiak
TGen Senior Science Writer
602-343-8704
[email protected]
